Mumbai's Identical Brains Studios listed on NSE SME at ₹95, a 75.93% premium over its IPO price of ₹54 per share.

Identical Brains Studios (IBS), a Mumbai-based VFX firm, was listed on the NSE Emerge platform on December 26 with a significant 76% premium over its IPO price.

The company's shares were listed at ₹95 per share on the NSE SME platform, compared to the issue price of ₹54, achieving a premium of 75.93%.

The IPO, valued at ₹20 crore, was open for subscription from December 18 to December 20, with a price band of ₹51–₹54 per share and a lot size of 2,000 shares.

IBS is a prominent VFX company headquartered in Mumbai, known for delivering innovative and high-quality visual effects work in the film and entertainment industry.

In FY23, the company recorded ₹8.04 crore in revenue from operations and a profit (PAT) of ₹1.61 crore.

For FY24, the revenue from operations surged to ₹20.08 crore, while profit after tax (PAT) climbed to ₹5.34 crore.

The company achieved over 2.5 times growth in revenue and a threefold increase in profits in FY24 compared to FY23, showcasing robust financial performance.

The successful IPO debut and impressive financial growth indicate strong market confidence and a promising future for IBS in the VFX industry.